A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jan 2018

At a glance

  • Drugs Brincidofovir (Primary)
  • Indications Adenovirus infections; Cytomegalovirus infections; Monkeypox; Smallpox; Viral infections
  • Focus Adverse reactions
  • Sponsors Chimerix
  • Most Recent Events

    • 05 Jan 2018 According to a Chimerix media release, the company expects to provide data in the second half of 2018.
    • 05 Jan 2018 Status changed from recruiting to completed, according to a Chimerix media release.
    • 08 Nov 2017 According to a Chimerix media release, data will be reported in early 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top